Previous Section Index Home Page

23 Apr 2007 : Column 955W—continued

Small Businesses: Greater London

Mr. Love: To ask the Secretary of State for Trade and Industry what steps his Department is taking to improve the competitiveness of small retail businesses in London; and if he will make a statement. [127846]

Margaret Hodge: Responsibility for improving the competitiveness of small businesses in London has been largely devolved to the London Development Agency.

The LDA through funding from the DTI pursues regional economic development and regeneration to reduce economic imbalances and improve competitiveness as well as providing publicly funded business support through Business Link. Small retailers are eligible for the same range of support measures as other small businesses.

The DTI Retail Unit also works with the sector to raise its productivity and improve its competitiveness by facilitating better regulation, incentivising innovation and encouraging good practice in areas such as skills, employment, international trade and environmental sustainability.

Stem Cells: Research

Mr. Amess: To ask the Secretary of State for Trade and Industry what the evidential basis was for the statement made by Sir David King at a public seminar organised by the Science and Technology Committee that extracting stem cells from human-animal hybrid embryos would enable scientists to learn more about diseases such as Alzheimer's; and if he will make a statement. [130836]

Malcolm Wicks: Because of their ability to differentiate into different cells and tissues, it is generally recognised by the scientific community that stem cells hold potential for the development of new cellular based treatments for diseases and injuries such as spinal cord injuries, Parkinson's disease, Alzheimer's, diabetes and heart tissue damaged after a heart attack.


23 Apr 2007 : Column 956W

The Government's position is that if we are to find treatments and cures for currently unbeatable diseases, it is important that we do not unnecessarily restrict research avenues that might enable us to learn more about the development of stem cells. Such research must be carried out within a suitable regulatory framework that results from an open debate with the public and the research community and commands broad public support. We welcome the Science and Technology Committee's contribution to this conversation.

As Sir David King is an independent chief scientific advisor, the hon. Member for Southend,West may wish to write to him to seek further information regarding his discussion at the seminar.

Health

Accident and Emergency Departments: Greater London

Mr. Evennett: To ask the Secretary of State for Health which hospitals in London are considering reconfiguration of accident and emergency departments. [132790]

Andy Burnham: Any proposals for the reconfiguration of services are a matter for the national health service locally.

There is an established and clear process for managing formal public consultations on proposals for major service change so that the public and other stakeholders can help to inform the local debate.

Care Homes

Mr. Lansley: To ask the Secretary of State for Health when she expects to publish (a) her Department's response to the consultation on the draft national framework for continuing care and (b) the final national framework for continuing care. [131945]

Mr. Ivan Lewis: On 14 March I announced my intention to publish new national guidance around eligibility for NHS continuing care in June. This will respond to issues raised during the consultation and set out the new national framework.

Chester-Le-Street Community Hospital

Mr. Kevan Jones: To ask the Secretary of State for Health when she decided to visit the Chester-le-Street Community hospital on 9 March 2007; when her Department informed the hospital of her visit; and what the cost of the visit was. [127561]

Mr. Ivan Lewis: The Secretary of State decided to visit Chester-le-Street Community hospital on 8 March 2007.

County Durham PCT suggested that the Secretary of State visit Chester-le-Street hospital on 7 March. This followed a request from the Department of Health, and in turn NHS North East.

All travel is undertaken in accordance with the Ministerial Code and Travel by Ministers.


23 Apr 2007 : Column 957W

Deep Vein Thrombosis

Mrs. Hodgson: To ask the Secretary of State for Health how many cases of deep vein thrombosis were recorded in each health authority in England in the last
23 Apr 2007 : Column 958W
12 months for which figures are available; and how many there were in each of the last five years. [131175]

Caroline Flint: The information is in the following table.

Finished consultant episodes( 1) for deep vein thrombosis in national health service hospitals, England( 2)
Finished consultant episodes
Strategic health authority of treatment 2000-01 2001-02 2002-03 2003-04 2004-05 2005-06

Q01

Norfolk, Suffolk and Cambridgeshire

2,093

2,147

2,207

2,292

2,121

2,097

Q02

Bedfordshire and Hertfordshire

1,188

1,172

1,282

1,426

1,046

786

Q03

Essex

963

884

970

809

782

868

Q04

North West London

1,244

1,380

1,422

1,189

1,176

1,988

Q05

North Central London

625

711

684

782

675

923

Q06

North East London

957

1,162

1,419

1,391

1,545

1,786

Q07

South East London

3,112

1,954

2,856

3,123

2,922

2,729

Q08

South West London

574

584

736

1,141

1,132

1,054

Q09

Northumberland, Tyne and Wear

1,227

1,293

1,233

1,399

1,264

1,355

Q10

County Durham and Tees Valley

775

855

1,482

1,381

1,203

1,325

Q11

North And East Yorkshire and Northern Lincolnshire

1,342

1,529

1,582

1,579

1,343

1,273

Q12

West Yorkshire

1,098

1,198

1,162

2,061

2,032

2,544

Q13

Cumbria and Lancashire

1,000

1,250

2,042

1,991

1,791

1,844

Q14

Greater Manchester

1,738

2,756

3,445

3,558

3,905

3,663

Q15

Cheshire and Merseyside

2,776

3,276

3,031

3,117

2,973

3,322

Q16

Thames Valley

1,271

1,101

1,083

1,194

1,159

1,171

Q17

Hampshire and Isle Of Wight

1,345

1,437

1,532

1,690

1,620

1,545

Q18

Kent and Medway

1,267

1,337

1,695

1,637

1,390

1,551

Q19

Surrey and Sussex

837

834

1,394

1,370

1,422

1,390

Q20

Avon, Gloucestershire and Wiltshire

2,463

2,608

3,052

3,323

2,929

3,470

Q21

South West Peninsula

1,765

1,885

1,527

1,549

1,353

1,362

Q22

Dorset and Somerset

1,269

1,255

1,451

1,089

1,099

1,066

Q23

South Yorkshire

1,246

1,711

1,783

1,805

1,513

1,515

Q24

Trent

2,620

2,502

2,387

2,240

2,302

2,259

Q25

Leicestershire, Northamptonshire and Rutland

1,316

1,079

1,082

1,077

932

1,127

Q26

Shropshire and Staffordshire

1,264

1,259

1,258

1,340

1,263

1,368

Q27

Birmingham and the Black Country

1,739

1,938

2,696

2,565

2,330

2,388

Q28

West Midlands South (Coventry, Warwickshire, Herefordshire and Worcestershire)

1,106

939

1,049

1,173

1,081

1,183

Y

Not known

5,567

3,574

0

4

0

0

Total

45,787

45,610

47,542

49,295

46,303

48,952

(1) Finished Consultant Episode (FCE). An FCE is defined as a period of admitted care under on consultant within one health care provider. Please note that the figures do not represent the number of patients, as a person may have more than one episode of care within a year. (2 )The figures are based on any diagnosis rather than main or principle diagnosis. They do not include cases treated by their general practitioner or as an out-patient.

Next Section Index Home Page